Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study

Gastrointestinal Cancer

Gravida and birth outcomes prior to and after diagnosis of early age onset colorectal cancer among female patients: Population-based epidemiologic studies

Cancer Epidemiol Biomarkers Prev

Oveisi N, Sayre EC, Gill S, Cheng V, Cheng V, Brotto LA, Peacock S, McTaggart-Cowan H, Hanley GE, Srikanthan A, De Vera MA

doi: 10.1158/1055-9965.EPI-25-0442

Gastrointestinal Cancer

Snapshot cohort study on early-onset colorectal cancer in Northwestern Switzerland - are we doing enough or can we do more?

Int J Surg

Erdem S, Gros H, Gass JM, Huber AK, Worni M, Henschel M, Viehl CT, Müller A, Zingg U, Stimpfle D, Galli R, Rodjakovic D, Hartel M, Nebiker C, Simon T, Happ S, Holzgang M, Di Pietro Martinelli C, Eisner L, Teixeira da Cunha S, Sivalingam K, Gebhardt L, Klasen JM, Friedrich U, Denhearynck K, Müller-Stich B, Steinemann D, Taha-Mehlitz S, von Strauss Und Torney M

doi: 10.1097/JS9.0000000000002964

Gastrointestinal Cancer

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

Int J Cancer

Potthoff K, Uhlig J, Jacobasch L, Müller L, Reiser M, de Buhr R, Polata S, Gerger A, Zehrer V, Amann A, Göhler T, Serrer L, Schröder J, Semsek D, Köhler A, Stübs P, Prager G, Siebenbach HU, Schuch A, Marschner N

doi: 10.1002/ijc.70139

Lung, Respiratory and Thoracic Cancer

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor (R) Classification for Lung Cancer. Results from an International Survey among Pathologists and Thoracic Surgeons

J Thorac Oncol

Hoffmann H, Nicholson AG, Detterbeck FC, Tsao MS, Ostrowski M, Rami-Porta R, Borczuk A, Marino M, Travis WD, Van Schil PE, Edwards J, Members of the R-Subcommittee, and Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards

doi: 10.1016/j.jtho.2024.12.007

Gastrointestinal Cancer

Prognosis of early-onset versus late-onset sporadic colorectal cancer: Systematic review and meta-analysis

Eur J Cancer

Carbone F, Spinelli A, Ciardiello D, Realis Luc M, de Pascale S, Bertani E, Fazio N, Fumagalli Romario U

doi: 10.1016/j.ejca.2024.115172

Lung, Respiratory and Thoracic Cancer

Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study

Lung Cancer

Tafur A, Sebai A, Shi Z, Wei J, Tran H, Zheng SL, Krantz S, Hensing T, Mansfield AS, Xu J

doi: 10.1016/j.lungcan.2025.108712

Breast Cancer

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies

Int J Cancer

García-Saenz JA, Spera G, Pollán M, Bermejo B, Ruiz-Borrego M, Chan A, Martín M, Guerrero-Zotano Á, Calvo L, Rodríguez-Lescure Á, Marín M, Chap L, Crown J, Pienkowski T, Bee V, Casas M, Polonio Ó, Bezares S, Slamon D

doi: 10.1002/ijc.35432

Gastrointestinal Cancer

Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort

Int J Cancer

van Nassau SCMW, Zwart K, van der Baan FH, Vink GR, Elferink MAG, Snaebjornsson P, May AM, Koopman M, Roodhart JML

doi: 10.1002/ijc.35410

Lung, Respiratory and Thoracic Cancer

Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study

Lung Cancer

Wheatley-Price P, Navani V, Pabani A, Routy B, Snow S, Denault MH, Kim Y, Syed I, Devost N, Hui D, Qadeer RA, Arora P, Velummailum R, Springford A, McKibbon C, Ho C

doi: 10.1016/j.lungcan.2025.108583

Related content

Gravida and birth outcomes prior to and after diagnosis of early age onset colorectal cancer among female patients: Population-based epidemiologic studies

Snapshot cohort study on early-onset colorectal cancer in Northwestern Switzerland - are we doing enough or can we do more?

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor (R) Classification for Lung Cancer. Results from an International Survey among Pathologists and Thoracic Surgeons

Prognosis of early-onset versus late-onset sporadic colorectal cancer: Systematic review and meta-analysis

Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study

Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies

Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort

Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study